| ■ 영문 제목 : Global Osteoporosis Drugs Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02125 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 91 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 골다공증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (흡수 억제제, 아나볼릭제)와 용도별 시장규모 (여성, 남성) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 골다공증 치료제 시장 점유율 - 지역별 골다공증 치료제 시장규모 - 주요지역의 종류별 시장규모 (흡수 억제제, 아나볼릭제) - 주요지역의 용도별 시장규모 (여성, 남성) - 미주의 골다공증 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 골다공증 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 골다공증 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 골다공증 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 골다공증 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Eli Lilly, Novartis, Pfizer, Amgen, Merck, Novo nordisk, Actavis, Roche - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Osteoporosis Drugs will have significant change from previous year. By the most conservative estimates of global Osteoporosis Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Osteoporosis Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Osteoporosis Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Antiresorptive Drugs
Anabolic Drugs
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Female
Male
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Eli Lilly
Novartis
Pfizer
Amgen
Merck
Novo nordisk
Actavis
Roche
1 Scope of the Report 2 Executive Summary 3 Global Osteoporosis Drugs by Company 4 Osteoporosis Drugs by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Osteoporosis Drugs Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Osteoporosis Drugs Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Antiresorptive Drugs Table 3. Major Players of Anabolic Drugs Table 4. Global Osteoporosis Drugs Sales by Type (2016-2021) & (K Units) Table 5. Global Osteoporosis Drugs Sales Market Share by Type (2016-2021) Table 6. Global Osteoporosis Drugs Revenue by Type (2016-2021) & ($ million) Table 7. Global Osteoporosis Drugs Revenue Market Share by Type (2016-2021) Table 8. Global Osteoporosis Drugs Sale Price by Type (2016-2021) Table 9. Global Osteoporosis Drugs Sales by Application (2016-2021) & (K Units) Table 10. Global Osteoporosis Drugs Sales Market Share by Application (2016-2021) Table 11. Global Osteoporosis Drugs Value by Application (2016-2021) Table 12. Global Osteoporosis Drugs Revenue Market Share by Application (2016-2021) Table 13. Global Osteoporosis Drugs Sale Price by Application (2016-2021) Table 14. Global Osteoporosis Drugs Sales by Company (2019-2021) & (K Units) Table 15. Global Osteoporosis Drugs Sales Market Share by Company (2019-2021) Table 16. Global Osteoporosis Drugs Revenue by Company (2019-2021) ($ Millions) Table 17. Global Osteoporosis Drugs Revenue Market Share by Company (2019-2021) Table 18. Global Osteoporosis Drugs Sale Price by Company (2019-2021) Table 19. Key Manufacturers Osteoporosis Drugs Producing Area Distribution and Sales Area Table 20. Players Osteoporosis Drugs Products Offered Table 21. Osteoporosis Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Osteoporosis Drugs Sales by Region (2016-2021) (K Units) Table 25. Global Osteoporosis Drugs Sales Market Share by Region (2016-2021) Table 26. Global Osteoporosis Drugs Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Osteoporosis Drugs Revenue Market Share by Region (2016-2021) Table 28. Americas Osteoporosis Drugs Sales by Country (2016-2021) & (K Units) Table 29. Americas Osteoporosis Drugs Sales Market Share by Country (2016-2021) Table 30. Americas Osteoporosis Drugs Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Osteoporosis Drugs Revenue Market Share by Country (2016-2021) Table 32. Americas Osteoporosis Drugs Sales by Type (2016-2021) & (K Units) Table 33. Americas Osteoporosis Drugs Sales Market Share by Type (2016-2021) Table 34. Americas Osteoporosis Drugs Sales by Application (2016-2021) & (K Units) Table 35. Americas Osteoporosis Drugs Sales Market Share by Application (2016-2021) Table 36. APAC Osteoporosis Drugs Sales by Region (2016-2021) & (K Units) Table 37. APAC Osteoporosis Drugs Sales Market Share by Region (2016-2021) Table 38. APAC Osteoporosis Drugs Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Osteoporosis Drugs Revenue Market Share by Region (2016-2021) Table 40. APAC Osteoporosis Drugs Sales by Type (2016-2021) & (K Units) Table 41. APAC Osteoporosis Drugs Sales Market Share by Type (2016-2021) Table 42. APAC Osteoporosis Drugs Sales by Application (2016-2021) & (K Units) Table 43. APAC Osteoporosis Drugs Sales Market Share by Application (2016-2021) Table 44. Europe Osteoporosis Drugs Sales by Country (2016-2021) & (K Units) Table 45. Europe Osteoporosis Drugs Sales Market Share by Country (2016-2021) Table 46. Europe Osteoporosis Drugs Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Osteoporosis Drugs Revenue Market Share by Country (2016-2021) Table 48. Europe Osteoporosis Drugs Sales by Type (2016-2021) & (K Units) Table 49. Europe Osteoporosis Drugs Sales Market Share by Type (2016-2021) Table 50. Europe Osteoporosis Drugs Sales by Application (2016-2021) & (K Units) Table 51. Europe Osteoporosis Drugs Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Osteoporosis Drugs Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa Osteoporosis Drugs Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Osteoporosis Drugs Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Osteoporosis Drugs Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Osteoporosis Drugs Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa Osteoporosis Drugs Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Osteoporosis Drugs Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa Osteoporosis Drugs Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Osteoporosis Drugs Table 61. Key Application and Potential Industries of Osteoporosis Drugs Table 62. Key Challenges of Osteoporosis Drugs Table 63. Key Trends of Osteoporosis Drugs Table 64. Osteoporosis Drugs Distributors List Table 65. Osteoporosis Drugs Customer List Table 66. Global Osteoporosis Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 67. Global Osteoporosis Drugs Consumption Market Forecast by Region Table 68. Global Osteoporosis Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Osteoporosis Drugs Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Osteoporosis Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 71. Americas Osteoporosis Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Osteoporosis Drugs Sales Forecast by Region (2021-2026) & (K Units) Table 73. APAC Osteoporosis Drugs Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Osteoporosis Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 75. Europe Osteoporosis Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Osteoporosis Drugs Sales Forecast by Country (2021-2026) & (K Units) Table 77. Middle East & Africa Osteoporosis Drugs Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Osteoporosis Drugs Sales Forecast by Type (2021-2026) & (K Units) Table 79. Global Osteoporosis Drugs Sales Market Share Forecast by Type (2021-2026) Table 80. Global Osteoporosis Drugs Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Osteoporosis Drugs Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Osteoporosis Drugs Sales Forecast by Application (2021-2026) & (K Units) Table 83. Global Osteoporosis Drugs Sales Market Share Forecast by Application (2021-2026) Table 84. Global Osteoporosis Drugs Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Osteoporosis Drugs Revenue Market Share Forecast by Application (2021-2026) Table 86. Eli Lilly Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 87. Eli Lilly Osteoporosis Drugs Product Offered Table 88. Eli Lilly Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 89. Eli Lilly Main Business Table 90. Eli Lilly Latest Developments Table 91. Novartis Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 92. Novartis Osteoporosis Drugs Product Offered Table 93. Novartis Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 94. Novartis Main Business Table 95. Novartis Latest Developments Table 96. Pfizer Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 97. Pfizer Osteoporosis Drugs Product Offered Table 98. Pfizer Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 99. Pfizer Main Business Table 100. Pfizer Latest Developments Table 101. Amgen Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 102. Amgen Osteoporosis Drugs Product Offered Table 103. Amgen Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 104. Amgen Main Business Table 105. Amgen Latest Developments Table 106. Merck Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 107. Merck Osteoporosis Drugs Product Offered Table 108. Merck Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 109. Merck Main Business Table 110. Merck Latest Developments Table 111. Novo nordisk Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 112. Novo nordisk Osteoporosis Drugs Product Offered Table 113. Novo nordisk Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 114. Novo nordisk Main Business Table 115. Novo nordisk Latest Developments Table 116. Actavis Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 117. Actavis Osteoporosis Drugs Product Offered Table 118. Actavis Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 119. Actavis Main Business Table 120. Actavis Latest Developments Table 121. Roche Basic Information, Osteoporosis Drugs Manufacturing Base, Sales Area and Its Competitors Table 122. Roche Osteoporosis Drugs Product Offered Table 123. Roche Osteoporosis Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 124. Roche Main Business Table 125. Roche Latest Developments List of Figures Figure 1. Picture of Osteoporosis Drugs Figure 2. Osteoporosis Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Osteoporosis Drugs Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Osteoporosis Drugs Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Osteoporosis Drugs Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Antiresorptive Drugs Figure 10. Product Picture of Anabolic Drugs Figure 11. Global Osteoporosis Drugs Sales Market Share by Type in 2020 Figure 12. Global Osteoporosis Drugs Revenue Market Share by Type (2016-2021) Figure 13. Osteoporosis Drugs Consumed in Female Figure 14. Global Osteoporosis Drugs Market: Female (2016-2021) & (K Units) Figure 15. Osteoporosis Drugs Consumed in Male Figure 16. Global Osteoporosis Drugs Market: Male (2016-2021) & (K Units) Figure 17. Global Osteoporosis Drugs Sales Market Share by Application (2016-2021) Figure 18. Global Osteoporosis Drugs Revenue Market Share by Application in 2020 Figure 19. Osteoporosis Drugs Revenue Market by Company in 2020 ($ Million) Figure 20. Global Osteoporosis Drugs Revenue Market Share by Company in 2020 Figure 21. Global Osteoporosis Drugs Sales Market Share by Regions (2016-2021) Figure 22. Global Osteoporosis Drugs Revenue Market Share by Region in 2020 Figure 23. Americas Osteoporosis Drugs Sales 2016-2021 (K Units) Figure 24. Americas Osteoporosis Drugs Revenue 2016-2021 ($ Millions) Figure 25. APAC Osteoporosis Drugs Sales 2016-2021 (K Units) Figure 26. APAC Osteoporosis Drugs Revenue 2016-2021 ($ Millions) Figure 27. Europe Osteoporosis Drugs Sales 2016-2021 (K Units) Figure 28. Europe Osteoporosis Drugs Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Osteoporosis Drugs Sales 2016-2021 (K Units) Figure 30. Middle East & Africa Osteoporosis Drugs Revenue 2016-2021 ($ Millions) Figure 31. Americas Osteoporosis Drugs Sales Market Share by Country in 2020 Figure 32. Americas Osteoporosis Drugs Revenue Market Share by Country in 2020 Figure 33. Americas Osteoporosis Drugs Sales Market Share by Type in 2020 Figure 34. Americas Osteoporosis Drugs Sales Market Share by Application in 2020 Figure 35. United States Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Osteoporosis Drugs Sales Market Share by Region in 2020 Figure 40. APAC Osteoporosis Drugs Revenue Market Share by Regions in 2020 Figure 41. APAC Osteoporosis Drugs Sales Market Share by Type in 2020 Figure 42. APAC Osteoporosis Drugs Sales Market Share by Application in 2020 Figure 43. China Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 47. India Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Osteoporosis Drugs Sales Market Share by Country in 2020 Figure 50. Europe Osteoporosis Drugs Revenue Market Share by Country in 2020 Figure 51. Europe Osteoporosis Drugs Sales Market Share by Type in 2020 Figure 52. Europe Osteoporosis Drugs Sales Market Share by Application in 2020 Figure 53. Germany Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 54. France Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Osteoporosis Drugs Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Osteoporosis Drugs Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Osteoporosis Drugs Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Osteoporosis Drugs Sales Market Share by Application in 2020 Figure 62. Egypt Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Osteoporosis Drugs Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles |
| ※본 조사보고서 [세계의 골다공증 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02125) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 골다공증 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |